166 related articles for article (PubMed ID: 27983930)
1. Downregulation of Ubiquitin-Specific Protease 22 Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Osteosarcoma Cells.
Zhang D; Jiang F; Wang X; Li G
Oncol Res; 2017 May; 25(5):743-751. PubMed ID: 27983930
[TBL] [Abstract][Full Text] [Related]
2. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
3. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
4. BRCA1-Associated Protein-1 Suppresses Osteosarcoma Cell Proliferation and Migration Through Regulation PI3K/Akt Pathway.
Gao S; Sun H; Cheng C; Wang G
DNA Cell Biol; 2017 May; 36(5):386-393. PubMed ID: 28256910
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
6. ZCCHC12 promotes the progression of osteosarcoma via PI3K/AKT pathway.
Cui Y; Dong YY
Aging (Albany NY); 2022 Sep; 14(18):7505-7516. PubMed ID: 36126191
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Homeobox B7 Inhibits the Tumorigenesis and Progression of Osteosarcoma.
Yang L; Xie F; Li S
Oncol Res; 2017 Aug; 25(7):1089-1095. PubMed ID: 27983923
[TBL] [Abstract][Full Text] [Related]
8. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-145 promotes epithelial-mesenchymal transition via regulating Snail in osteosarcoma.
Zhang Z; Zhang M; Chen Q; Zhang Q
Cancer Gene Ther; 2017 Feb; 24(2):83-88. PubMed ID: 28186090
[TBL] [Abstract][Full Text] [Related]
11. Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma.
Tian Y; Tang B; Wang C; Wang Y; Mao J; Yao Y; Gao Z; Liang R; Ye M; Cai S; Wang L
Cell Death Dis; 2021 Jul; 12(7):678. PubMed ID: 34226501
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-503 represses epithelial-mesenchymal transition and inhibits metastasis of osteosarcoma by targeting c-myb.
Guo X; Zhang J; Pang J; He S; Li G; Chong Y; Li C; Jiao Z; Zhang S; Shao M
Tumour Biol; 2016 Jul; 37(7):9181-7. PubMed ID: 26768615
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
14. SLC34A2 Regulates the Proliferation, Migration, and Invasion of Human Osteosarcoma Cells Through PTEN/PI3K/AKT Signaling.
Liu X; Zhou X; Xu H; He Z; Shi X; Wu S
DNA Cell Biol; 2017 Sep; 36(9):775-780. PubMed ID: 28777670
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract][Full Text] [Related]
16.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
17. The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer.
Xiao Y; Liu S; Li J; Dai W; Tang W; Xiang L; Zhang W; Lin J; Wang J; Wu X; Liu G; Liu Y; Chen Y; Zhu H; Wang Y; Lin Z; Yang Q; Chen T; Sun Y; Li A; Xiong J; Wang J
Cell Oncol (Dordr); 2020 Dec; 43(6):1017-1033. PubMed ID: 32857323
[TBL] [Abstract][Full Text] [Related]
18. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract][Full Text] [Related]
19. lncRNA SNHG1 negatively regulates miRNA‑101‑3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma.
Deng R; Zhang J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1157-1166. PubMed ID: 30592267
[TBL] [Abstract][Full Text] [Related]
20. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
